Re: HSC TESTING AFTER CRYOPRESERVATION

From: Andrew Fryga (frygaa@cryptic.rch.unimelb.edu.au)
Date: Wed Aug 09 2000 - 19:03:11 EST


	Reasonable CD34 and CFC correlations can be achieved between the pre cryo
and post thaw counts on PBSC products. CD34 analysis must be performed
using a no antibody wash method for the thaw sample at least (best for
both) and a single platform "bead" method is worth considering. We use the
Stem Cell Technologies, Methocult H4434 for our CFC assay, this has
produced more reproducible results. I have included an abstract and some
grafts.

	Andrew Fryga
	Bone Marrow Transplant Laboratory
	Royal Childrens Hospital
	Melbourne
	Australia




At 08:08 9/08/00 +0200, you wrote:
>   Actually we also performing cell enumeration CD34, and CFU after
>thawing. In France many groups do not. However we think that if it do not
>stop the infusion (results were obtained after infusion) it participate to
>the quality control of the entire process. Indeed there is big differences
>between pre- and post-cryopreservation results. But it is difficult to know
>why. We performe dead cell evaluation by flow cytometry (IP) concurrently
>with CD34 evaluation. Philippe Bourin
>
>  Liza McGuire wrote :  Good-day to you flowers, I am searching for
>guidelines and/or standards that involve testing peripheral blood stem cell
>collections post cryopreservation. At this point our laboratory is testing
>for viability, sterility, CD34 enumeration and CFU at the point of
>collection (fresh sample) as well as at the point of infusion (post thaw).
>Is it necessary to do all of the testing post cryopreservation? Naturally,
>the results will not correlate with pre cryopreservation. Furthermore, they
>are time consuming and the decision for the stem cell infusion dose has
>already been made. I would consider any post cryopreservation data points
>to be useful for future clinical research studies. What do you think?I have
>checked into FAHCT guidelines and if I understood correctly the decision is
>left up to the laboratory director.I am trying to get a feel of what the
>"norm" might be. What is the consensus? I appreciate and I will be grateful
>for any input that you may have.Thanks a bunch in advance,Liza McGuire
>Bone Marrow Processing Lab
>Thomas Jefferson University Hospital
>130 S 9th Street, Rm. 400 Edison
>Philadelphia, PA 19107-5233
>(215)955-9646
>     Attachment Converted: "c:\eudora\fryga\attach\bourin1.vcf"





This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:56:00 EST